Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
None
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2011
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/24630 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Histone Deacetylase Inhibitors as Therapeutic Agents for Cancer Therapy: Drug Metabolism and Pharmacokinetic Properties
- Histone Deacetylases (HDACs) as Key Targets in Metabolic Disorders
- Discovery of Small Molecule Inhibitors for Histone Methyltransferases in Cancer
- Pharmacogenomics Dictate Pharmacokinetics: Polymorphisms in Drug-Metabolizing Enzymes and Drug-Transporters
- DNA Methylation and Histone Deacetylation: Interplay and Combined Therapy in Cancer
- Study of the Fluorescence Intensity of Histones HP1gamma, H3K9me3, H3K27me3, and Histone Deacetylases SIRT1 and SIRT6 in Dermal Fibroblasts of Patients with Breast Cancer and Patients at Risk of Cancer
- The Modification Strategies for Enhancing the Metabolic Stabilities and Pharmacokinetics of Aptamer Drug Candidates